Zacks Research Comments on Maximus' Q4 Earnings (NYSE:MMS)

Key Points

• Zacks Research cut its Q4 2026 EPS estimate for Maximus to $1.93 from $2.29 and maintains a “Strong Sell” rating. Its full-year 2026 forecast is now close to the $8.03 analyst consensus.
• Maximus recently reported quarterly EPS of $2.22, narrowly beating estimates, but revenue of $1.28 billion fell short of expectations and declined 5.1% year over year. The company’s fiscal 2026 EPS guidance remains $7.90–$8.20.
• Shares opened at $59.48, up 0.9%, while institutional investors own 97.21% of the stock. Maximus also declared a quarterly dividend of $0.33 per share, representing a 2.2% annualized yield.

Maximus, Inc. (NYSE:MMS - Free Report) - Zacks Research decreased their Q4 2026 earnings per share (EPS) estimates for Maximus in a report released on Wednesday, August 26th. Zacks Research analyst Team now forecasts that the health services provider will earn $1.93 per share for the quarter, down from their previous forecast of $2.29. Zacks Research currently has a "Strong Sell" rating on the stock. The consensus estimate for Maximus' current full-year earnings is $8.03 per share.

MMS has been the topic of several other research reports. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Maximus in a report on Monday, August 17th. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Maximus has an average rating of "Reduce".

Maximus Stock Up 0.9%

Shares of Maximus stock opened at $59.48 on Friday. Maximus has a one year low of $52.73 and a one year high of $100.00. The company has a market cap of $3.11 billion, a P/E ratio of 8.79 and a beta of 0.59. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The firm has a fifty day moving average of $57.58 and a two-hundred day moving average of $63.66.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, beating analysts' consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. Maximus's quarterly revenue was down 5.1% on a year-over-year basis. During the same period last year, the firm posted $2.16 EPS. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS.

Hedge Funds Weigh In On Maximus

Large investors have recently made changes to their positions in the stock. BlackRock Inc. purchased a new stake in Maximus during the second quarter worth about $400,186,000. California State Teachers Retirement System grew its position in Maximus by 5,229.9% during the second quarter. California State Teachers Retirement System now owns 3,365,376 shares of the health services provider's stock worth $180,923,000 after buying an additional 3,302,234 shares during the period. Reinhart Partners LLC. increased its holdings in Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock valued at $106,575,000 after buying an additional 1,127,346 shares in the last quarter. Norges Bank purchased a new position in Maximus in the fourth quarter valued at about $60,393,000. Finally, Bank of America Corp DE acquired a new stake in shares of Maximus during the 2nd quarter valued at approximately $31,487,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. Maximus's dividend payout ratio is 19.50%.

Key Stories Impacting Maximus

Here are the key news stories impacting Maximus this week:

• Positive Sentiment: Zacks Research raised its FY2028 EPS forecast to $9.15 from $8.94, and increased estimates for Q2 2027, Q1 2028, and Q2–Q3 2028. These upgrades suggest some confidence in Maximus’ longer-term earnings potential.
• Neutral Sentiment: Zacks Research continues to rate Maximus “Strong Sell,” even as its FY2027 forecast remains relatively strong at $8.37 EPS and its FY2028 estimate rises. The longer-term upgrades therefore have limited immediate impact while the overall rating remains negative.
• Negative Sentiment: Zacks cut its FY2026 EPS forecast to $8.07 from $8.41, bringing it only slightly above the broader consensus estimate of $8.03. The firm also lowered estimates for Q4 2026 to $1.93 from $2.29, Q1 2027 to $1.93 from $1.94, Q3 2027 to $2.27 from $2.33, Q4 2027 to $1.92 from $1.95, and FY2027 to $8.37 from $8.43.

Maximus Company Profile

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source